PKM and gastric carcinoma: PKM2 siRNA significantly increased expression of E-cadherin and decreased expression of N-cadherin and vimentin, compared with the control group (p < 0.05), in the human gastric carcinoma cell lines MKN-45 (Figure 2(a)) and SGC-7901 (Figure 2(b)).